Efficacy and Outcomes of Definitive Treatment in Egyptian Patients with Cervical Cancer: A Retrospective Study In Ain Shams University Hospitals

Abstract

Cancer cervix is the fourth most common malignancy in females worldwide, with an estimated 527,600 new cases worldwide (Farley et al., 2012), it remains a leading reason of cancer-related death for females in developing countries. Cancer cervix remains a significant cause of morbidity and mortality in females. The highest incidence rates were in Central and South America and sub-Saharan Africa. The lowest rates were in the Middle East, Northern America, Australia and New Zealand, China, and Western Europe (Farley et al., 2012). Cancer cervix is decreasing in the United States of America due to the wide use of screening. But it is increasing in developing countries (275,000 deaths/year), since screening is not available to many females. Effect